Date: October 18, 2011

Description: Prostate cancer presents a global public health dilemma. While screening with prostate specific antigen (PSA) has led to more men diagnosed with prostate cancer than in previous years, the potential for negative effects from over-diagnosis and treatment cannot be ignored.

It is estimated that nearly 23,000 protstate cancer diagnosis will be missed or delayed due to the COVID-19 pandemic.

Join Our Newsletter